S.No | Product | Status |
---|---|---|
1 | Vildagliptin | Commercialised |
2 | Tapentadol Hydrochloride | Commercialised |
3 | Tadalafil | Commercialised |
4 | Rivaroxaban | Commercialised |
5 | Obeticholic acid | Development Completed |
6 | Brivaracetam | Development Completed |
7 | Remogiflozin Etabonate | Development Completed |
8 | Obeticholic acid | Development Completed |
9 | Empagliflozin | Development Completed |
10 | Canagliflozin | Development Completed |
11 | Safinamide | U/Development |
12 | Ferric Carboxy maltose | U/Development |
13 | Bilastine | U/Development |
14 | Bempedoic acid | U/Development |
15 | Sarecycline | U/Development |
Note :- Some of the products may have patent rights in one or more countries and any such product having an existing patent will not be offered/sold for commercial requirements. The final responsibility with respect to third party patent rights lies exclusively with the buyer.